Veriheal

NOVEMBER 21, 2023

As we reflect on the success of the 2022 recipients, we are thrilled to introduce the exceptional winners of the 2023 scholarship. To alleviate this burden, we awarded $5,000 scholarships to five outstanding individuals in 2022. Veriheal recognizes the financial challenges students face in pursuing higher education.

Research and Development 108

Research and Development Consumption Education Data 108

Cannabis Law Report

JULY 18, 2022

July 18, 2022. According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 By Robert Szyba & Sydney Jenkins. million marijuana plants and conducted more than 6,600 marijuana related arrests.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JUNE 24, 2022

People are using these medicines; we have data that it’s safe, that there’s not a public health and safety risk in those cities that have decriminalized (them) so far. “So, the initiative that we’re proposing would make the facilitation, possession, (and) use no longer a crime,” Forester told Denver7.

Decriminalization 52

Decriminalization Data Safety Policy 52

Cannabis Law Report

JULY 8, 2022

Jul 08, 2022. CALIFORNIA – Delivering on calls to strengthen uniformity in cannabis laboratory testing procedures, the Department of Cannabis Control (DCC) is proposing standards to lab testing methods across the state and is accepting public comments until August 2, 2022. 1, 2022, from 9 a.m.

Cannabinoids 59

Cannabinoids Safety Packaging Cannabis 59

Cannabis Law Report

MAY 6, 2022

POSTED ON MAY 5, 2022. Washington, DC: Legal marijuana states generated more revenue from retail cannabis sales than they did from alcohol sales, according to data provided by the Institute on Taxation and Economic Policy (ITEP). NORML-Factsheet-Marijuana-Regulation-Impact-on-Health-Safety-and-Economy. billion last year.

Marijuana 52

Marijuana Safety Retail Collective 52

Cannabis Law Report

MARCH 17, 2022

Deadline to apply: March 18, 2022 by 5:00 p.m. Deadline to apply: March 31, 2022 by 5:00 p.m. Data Manager. Deadline to apply: March 31, 2022 by 5:00 p.m. Quote/bid response deadline: March 24, 2022 by 5 p.m. Please share this information with your networks. We look forward to hearing from you! Procurements.

Compliance 52

Compliance Compliance Research and Development Data 52

Cannabis Law Report

JULY 22, 2022

July 21, 2022 08:00 ET | Source: Metrc LLC. July 21, 2022 (GLOBE NEWSWIRE) — Metrc , the most trusted and experienced provider of cannabis regulatory systems in the U.S., July 21, 2022 (GLOBE NEWSWIRE) — Metrc , the most trusted and experienced provider of cannabis regulatory systems in the U.S., LAKELAND, Fla.,

Data 52

Data Programs Access Compliance 52

Cannabis Law Report

AUGUST 16, 2022

16, 2022 (GLOBE NEWSWIRE) — Metrc , the most trusted and experienced provider of cannabis regulatory systems in the U.S., This marks Metrc’s 23 rd government contract to date and sixth so far in 2022. The State plans to begin accepting licensing applications for businesses on September 1, 2022. “We LAKELAND, Fla.,

Seed-To-Sale 52

Seed-To-Sale Supply Chain Data Patients 52

SpeedWeed

MARCH 26, 2021

In March, last year the US Food and Drug Administration (FDA) requested specific data on liver toxicity data after saying it believed from CBD use posed ‘real risks’ to human health. Data To Be Used In UK . UK Requires CBD Safety Evidence. It will allow us to differentiate ourselves from the people that don’t.

CBD 52

CBD Business Safety Data 52

Cannabis Law Report

MARCH 17, 2022

LAKELAND, Fla. , March 17, 2022 /PRNewswire/ — Metrc , the most trusted and experienced provider of cannabis regulatory systems in the U.S., Metrc will implement its robust track-and-trace platform to help facilitate the Minnesota Medical Cannabis Program’s data collection and regulatory oversight.

Data 52

Data Compliance Compliance Programs 52

Cannabis Law Report

JANUARY 12, 2022

Through the partnership, Maya’s Real World Evidence Platform will be one of the core services offered to the association’s members when it officially launches in Q4 of 2022. We don’t believe safety and access are opposing polarities that must be constantly balanced.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

SEPTEMBER 29, 2022

September 27, 2022. On September 22, 2022, Canada’s Minister of Health, Jean-Yves Duclos, and Minister of Mental Health and Addictions and Associate Minister of Health, Carolyn Bennett, announced the overdue legislative review of Canada’s Cannabis Act (Act). By Laura Weinrib , Alexis Levine and Alan Fraser. CANNABIS ACT.

Legislation 59

Legislation Consumption Safety Access 59

Cannabis Law Report

OCTOBER 22, 2021

To date, more than 50 novel compounds have been evaluated through collaborations with experienced contract research organizations for pharmacokinetic/pharmacodynamic profile, metabolic stability, receptor binding, and safety in order to identify preferred candidates for further development.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

AUGUST 16, 2022

August 16, 2022. To be eligible to apply for a conditional adult-use processor license, a processor must: Have applied for a cannabinoid hemp processor license before January 1, 2022; Hold an active cannabinoid hemp processor license issued by the OCM; and. The application window opened on June 28, 2022 and closes on August 31, 2022.

Supply Chain 52

Supply Chain Conditions Cannabinoids Programs 52

Cannabis Law Report

APRIL 14, 2022

Similar issues arise under state and federal employee safety and worker Right-to-Know laws, as employees must be educated on the chemicals present and proper handling and risk management procedures. Since growing cannabis has not always been legal, growers did not always choose pesticides that were “approvable” by EPA. Next Steps.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

APRIL 5, 2022

April 05, 2022 (GLOBE NEWSWIRE) — Metrc, the most trusted and experienced provider of cannabis regulatory systems in the U.S., Metrc will help facilitate Mississippi’s medical cannabis program’s data collection and regulatory oversight through its robust track-and-trace platform. Their third new state contract in as many weeks.

Safety 52

Safety Patients Dispensary Compliance 52

Veriheal

JUNE 30, 2023

The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

AUGUST 31, 2022

Harocopos and his team explain that OPCs, also known as supervised/safe consumption sites, are considered to be “health care facilities that aim to improve individual and community health, increase public safety and reduce the consequences of drug use, including overdose deaths, public drug use and syringe litter.” The Research Letter.

Consumption 104

Consumption Data Treatment Collective 104

Veriheal

JUNE 1, 2023

These research submissions may have left regulators skeptical about the safety of this relatively affordable, highly productive herb for livestock. In earlier federally funded research in 2022 , scientists found that ingesting hemp reduces stress in cattle; other research says CBD may reduce pain and tension in horses.

THC 98

THC Hemp CBD Supply Chain 98

Veriheal

DECEMBER 23, 2022

Dr. Maxwell’s team also collected data contained in samples sourced from California. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues. 74 solvents. 21 microbes.

Research and Development 96

Research and Development Agriculture Data Extraction 96

Canna Law Blog

JANUARY 17, 2023

In November 2022, the OLCC adopted and amended a suite of cannabis rules that became effective January 1, 2023. Oregon cannabis M&A continues at a decent pace despite a relatively sluggish 2022 in terms of sales to consumers. Change in business structure. Our M&A practitioners remain heavily involved in several major deals.

Retail 71

Retail Cannabis Conditions Business 71

Cannabis Law Report

FEBRUARY 20, 2022

Domestic carriers are staying away from the industry because of the immaturity of the market, but also because of a lack of data integrity and the stigma around the product. Looking Toward 2022. The majority of the carriers offering coverage to Canadian cannabis businesses are located outside the country.

Edibles 118

Edibles Hydroponic Retail Cannabis 118

SpeedWeed

JULY 29, 2021

The SB 21-111 states that a report must be submitted to the Governor between July 1, 2022 and July 1, 2023 with details about how the CBO spends its funds. According to most recent sales data on Colorado’s cannabis industry, the state has sold $962,071,139 between January and May of this year. View original article.

Data 52

Data Collective Business Cannabis 52

Cannabis Law Report

DECEMBER 26, 2021

Along with the previously completed in vitro assays, these studies serve as the benchmark for further preclinical work in 2022 and will contribute to regulatory submissions as the company advances its DMT program. EBRX-101 on Track to Submit Regulatory Package for Human DMT Clinical Trial. About Entheon Biomedical Corp.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

AUGUST 5, 2019

The two-year experiment is being overseen by the French Agency for Drug Safety (ANSM), which drew up a 13-name committee to explore the possibilities of reform in one of Europe’s largest markets in December 2018. Any tweaking of laws will only happen post-2022 when the report has been fully digested by the relevant parties.

Medicine 60

Medicine Patients Digestion Epilepsy 60

Cannabis Law Report

MARCH 11, 2022

2022 Regular Session. ” The MED conducted 604 underage compliance checks at dispensaries in 2019, according to department data, but that number dropped to 118 in 2020 and 80 in 2021. BILL SUMMARY. Improve Marijuana Industry Regulation. Concerning measures to improve marijuana industry regulation. Liquor, Tobacco, & Marijuana.

Legislation 105

Legislation Seed-To-Sale Compliance Compliance 105

Cannabis Law Report

DECEMBER 4, 2019

CBD market comes shortly after the country’s Food and Drug Administration issued a statement last month that it cannot conclude the cannabis compound’s safety in human or animal food products. billion by 2022. government agency said on its website. CBD market, pegging retail sales to reach US$3.5

CBD 59

CBD Supply Chain Safety Hemp 59

Cannabis Law Report

JULY 13, 2022

The 2022-23 budget and accompanying tax reform bill will provide significant and immediate relief to cannabis businesses, support equity operators, strengthen enforcement tools against illegal cannabis operators, and protect youth, environmental, and public safety programs funding.

Compliance 52

Compliance Compliance Supply Chain Environment 52

Cannabis Law Report

JUNE 19, 2022

June 14, 2022 02:00 AM Eastern Daylight Time. Beckley Psytech will use Ksana Health’s Effortless Assessment Research System (EARS), an end-to-end solution for mobile sensing, to collect passive mobile device meta data from clinical trial participant’s smartphones, in order to identify individual signals of potential response and relapse.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Cannabis Law Report

DECEMBER 2, 2021

Products that are listed as having been verified as meeting the minimum quality standards are unapproved medicines – there has been no assessment of their safety or efficacy. Airport Oaks, Mangere 2022. Sativex data sheet. Being listed here does not guarantee that these products are currently available in New Zealand.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Cannabis Law Report

DECEMBER 19, 2021

Products that are listed as having been verified as meeting the minimum quality standards are unapproved medicines – there has been no assessment of their safety or efficacy. Airport Oaks, Mangere 2022. Sativex data sheet. Being listed here does not guarantee that these products are currently available in New Zealand.

Medicine 52

Medicine Pharmaceutical THC Sativa 52

Cannabis Law Report

SEPTEMBER 8, 2022

By Evan Symon , September 8, 2022 1:44 pm. San Francisco joins a growing list of cities and countries that are taking a fresh look at these plant-based medicines, following science and data, and destigmatizing their use and cultivation. Resolution That Decriminalizes Psychedelic Drugs Passed By San Francisco Board of Supervisors.

Decriminalization 52

Decriminalization Legislation Safety Data 52

Cannabis Law Report

MAY 29, 2022

To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision. 12] DEA, Drug Scheduling, [link] (last visited May 13, 2022). [13] 1, 2022), [link]. [14]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Freedom Leaf

OCTOBER 15, 2018

Frontier Data predicts total sales of all CBD products in the U.S. billion by 2022. On July 23, the World Health Organization’s Expert Committee on Drug Dependence stated that “no public health problems have been associated with CBD use” and that “CBD has been found to be generally well tolerated with a good safety profile.”

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

JUNE 1, 2021

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” In Q1 2022, Canopy has expanded its portfolio of THC beverages with Tweed Iced Tea beverages (available in lemon and raspberry flavors, both with 5 mg THC) now shipping. Net revenue. Adjusted EBITDA 3.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98